JPMorgan will pay additional $100M to CFTC to settle trade surveillance lapses
By 
Aaron Nicodemus2024-05-24T15:59:00
A subsidiary of JPMorgan Chase will pay an additional $100 million to the Commodity Futures Trading Commission (CFTC) to settle charges it failed to adequately monitor and supervise its trading system.
The CFTC announced a $200 million fine Thursday against JPMorgan Securities for trade surveillance gaps created during the onboarding of a new system in 2021. The CFTC’s fine will be offset by $100 million, money the bank will pay to the Treasury Department’s Office of the Comptroller of the Currency and the Federal Reserve Board as part of a $348 million settlement announced in March for related trade surveillance failures.
JPMorgan previously disclosed it would pay a $100 million fine to a third regulator, now revealed as the CFTC, for the trade surveillance lapses.
Related articles
-
News BriefBroker-dealer BMO Capital Markets to pay $41M to settle trade supervision lapses
A broker-dealer subsidiary of Toronto-based BMO Financial Group will pay nearly $41 million in penalties to the Securities and Exchange Commission to settle allegations that its traders issued misleading disclosures on bonds for three years, causing $19 million in harm to its customers.
-
News BriefJPMorgan Chase to pay $151M in penalties, restitution to settle disclosure lapses
Two affiliates of JPMorgan Chase have agreed to pay $151 million to settle five separate enforcement actions for making misleading disclosures, breaching fiduciary duties, and other failures related to investors.
-
News BriefFINRA dings JPMorgan Securities $190K over registration, supervision failures
The Financial Industry Regulatory Authority fined JPMorgan Securities $190,000 for unregistered investment banking activities and not having a supervisory system reasonably designed to achieve compliance with FINRA registration requirements.
More from Regulatory Enforcement
-
News BriefCFPB ends probe into Meta’s financial advertising practices
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
-
News BriefTexas sues Johnson & Johnson, Kenvue over alleged misleading marketing of Tylenol
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
-
News BriefCFPB scraps bad-actor registry, citing cost-benefit issues
The Consumer Financial Protection Bureau shut down a registry of non-bank financial firms that broke consumer laws. The agency cites the costs being ”not justified by the speculative and unquantified benefits to consumers.”